Literature DB >> 8384236

Inhibition of interleukin-1 release and activity by the rat seminal vesicle protein SV-IV.

M L Vuotto1, G Peluso, D Mancino, G Colonna, A Facchiano, M T Ielpo, G Ravagnan, S Metafora.   

Abstract

SV-IV, a 9.8-kd protein isolated from rat seminal vesicle secretion, has been shown to have strong non-species-specific immunosuppressive, anti-inflammatory, antithrombotic, and antiphospholipase A2 properties. The present investigation was undertaken to determine the mechanism of action of its immunosuppressive effects. It was found that SV-IV is a potent inhibitor of interleukin-1 (IL-1) release from lipopolysaccharide (LPS)-activated human adherent monocytes and an effective inhibitor of IL-1-induced thymocyte proliferation. The ability of SV-IV to form a noncovalent dimeric association with IL-1 alpha but not with IL-1 beta, its ability to induce a marked decrease of IL-1 binding to its own receptors on the thymocyte surface, and its capacity to bind specifically to the macrophage plasma membrane might play an important role in the molecular mechanism of these inhibitory effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384236     DOI: 10.1002/jlb.53.3.214

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates alpha-thrombin activity: potential clinical implications.

Authors:  Marilena Lepretti; Susan Costantini; Gaetano Ammirato; Gaia Giuberti; Michele Caraglia; Angelo M Facchiano; Salvatore Metafora; Paola Stiuso
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

2.  Effect of protein SV-IV on experimental Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Caterina Romano-Carratelli; Concetta Bentivoglio; Immacolata Nuzzo; Nunzia Benedetto; Elisabetta Buommino; Anna Cozzolino; Maria Cartenì; Francesco Morelli; Maria Rosaria Costanza; Biancamaria Metafora; Vittoria Metafora; Salvatore Metafora
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

3.  SV-IV Peptide1-16 reduces coagulant power in normal Factor V and Factor V Leiden.

Authors:  Biagio Di Micco; Marilena Lepretti; Lidia Rota; Ilaria Quaglia; Paola Ferrazzi; Gianluca Di Micco; Pierpaolo Di Micco
Journal:  J Transl Med       Date:  2007-12-21       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.